Media & Events
Shardul Amarchand Mangaldas & Co. advises Trichem Group and its promoters on 100% stake sale to IMCD Group
July 2, 2025
Shardul Amarchand Mangaldas & Co. acted as legal counsel to the Trichem Group and its Promoters in connection with the sale of 100% equity stake in Trichem Healthcare Private Limited, Trichem Lifesciences Limited, and Chemistry & Health FZ LLC (Dubai) (“Target Entities”) to the IMCD Group. The Target Entities are engaged primarily in the businesses of indenting, distribution, manufacture and sale of high-quality Active Pharmaceutical Ingredients (“API”), pharmaceutical intermediates (“Intermediates”), and formulation solutions (“Formulations”).
The Shardul Amarchand Mangaldas & Co. team advised the Trichem Group and its Promoters in relation to the structuring of the transaction from a commercial and a regulatory perspective, and drafting and negotiating the transaction documents for each of the Target Entities. The team also provided comprehensive support and advice on execution logistics, fulfilment of conditions precedent, and closing date actions to facilitate a smooth completion of the transaction.
This strategic acquisition marks a significant milestone for the IMCD Group as it strengthens its presence in the high-growth life sciences sector in India and the Middle East. With India being a major global supplier of generic drugs, the acquisition of the Trichem Group—renowned for its high-quality APIs, Intermediates, and Formulations, and its regulatory expertise — will enable IMCD to enhance its pharmaceutical portfolio and deepen its market footprint. The deal will allow IMCD to leverage Trichem’s deep industry relationships across the globe and technical know-how and aligns with IMCD’s commitment towards sustainable value creation in the speciality chemicals and ingredients sector.
The transaction (M&A) team was led by Jay Gandhi, Partner; and comprised Kaustubh Verma, Partner; Ankit Parekh, Senior Associate; and Sanjana Kumar, Senior Associate. The transaction (M&A) team was supported by the Dispute Resolution team comprising Shreya Jain, Partner.